UAE Serialization Update

The Ministry of Health and Prevention, UAE, launched the Tatmeen Project, a platform for tracking and tracing serialized pharmaceutical products to fortify and secure the country's healthcare supply chains. The initiative strengthens the UAE's position with leading countries with advanced pharmaceutical safety solutions.

This legislation:

? Defines the specific categories of products relevant to the legislation.

? Applies to the entirety of the UAE territory.

? It becomes effective:

o Immediately prior to foreign product importation into the UAE.

o Immediately prior to domestic manufacture release into the UAE.

? Concludes with dispensing to patients / consumers.

? Manages exceptions such as batch recalls.

All products placed on the UAE market need to display a serialised unique identifier on the product secondary packaging. Also aggregated packaging (aggregated homogenous products or logistics unit) must display a serialised unique identifier. The appropriate serialised identifiers must be used to record the operational and transactional movements of the products throughout the supply chain and during dispensing to the patient / consumer. The information recorded by the participants must be transmitted to the Tatmeen traceability system where it is stored. The stored data is made available for regulatory purposes to the authorities of the UAE MoHAP departments.

The deadline for uploading and transferring data to Tatmeen portal is 13th December 2022.

Sample Data Encoded and sequence: GTIN(01) + Batch(10) + EXP(17) + Serial Number(21)

?UAE Traceability support below 2D data encoding sequence.

GTIN+SN+EXP+LOT

GTIN+SN+LOT+EXP

GTIN+EXP+SN+LOT

GTIN+EXP+LOT+SN

GTIN+LOT+EXP+SN

GTIN+LOT+SN+EXP